Importance of Race/Ethnicity in Clinical Trials
Authors:
- 6 December 2005
- journal article
- editorial
- Published by Wolters Kluwer Health in Circulation
- Vol. 112 (23) , 3654-3666
Abstract
No abstract availableKeywords
This publication has 74 references indexed in Scilit:
- A Comparison of Iothalamate-GFR and Serum Creatinine-Based OutcomesJournal of the American Society of Nephrology, 2004
- Will tomorrow's medicines work for everyone?Nature Genetics, 2004
- Race and Medicine2003
- Breast and Ovarian Cancer Risks Due to Inherited Mutations in BRCA1 and BRCA2Science, 2003
- Efficacy of angiotensin-converting enzyme inhibitors and beta-blockers in the management of left ventricular systolic dysfunction according to race, gender, and diabetic statusJACC, 2003
- Genetic Structure of Human PopulationsScience, 2002
- Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)JAMA, 2002
- Influence of Race or Ethnicity on Pharmacokinetics of DrugsJournal of Pharmaceutical Sciences, 1997
- Tests for interaction in epidemiologic studies: A review and a study of powerStatistics in Medicine, 1983
- Pathophysiology of hypertension in blacks and whites. A review of the basis of racial blood pressure differences.Hypertension, 1979